Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys.

MLA

Pichyangkul, S., et al. “Evaluation of the Safety and Immunogenicity of Plasmodium Falciparum Apical Membrane Antigen 1, Merozoite Surface Protein 1 or RTS,S Vaccines with Adjuvant System AS02A Administered Alone or Concurrently in Rhesus Monkeys.” Vaccine, vol. 28, no. 2, Dec. 2009, pp. 452–62. EBSCOhost, https://doi.org/10.1016/j.vaccine.2009.10.022.

APA

Pichyangkul, S., Tongtawe, P., Kum-Arb, U., Yongvanitchit, K., Gettayacamin, M., Hollingdale, M. R., Limsalakpetch, A., Stewart, V. A., Lanar, D. E., Dutta, S., Angov, E., Ware, L. A., Bergmann-Leitner, E. S., House, B., Voss, G., Dubois, M. C., Cohen, J. D., Fukuda, M. M., Heppner, D. G., & Miller, R. S. (2009). Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys. Vaccine, 28(2), 452–462. https://doi.org/10.1016/j.vaccine.2009.10.022

Chicago

Pichyangkul, S, P Tongtawe, U Kum-Arb, K Yongvanitchit, M Gettayacamin, M R Hollingdale, A Limsalakpetch, et al. 2009. “Evaluation of the Safety and Immunogenicity of Plasmodium Falciparum Apical Membrane Antigen 1, Merozoite Surface Protein 1 or RTS,S Vaccines with Adjuvant System AS02A Administered Alone or Concurrently in Rhesus Monkeys.” Vaccine 28 (2): 452–62. doi:10.1016/j.vaccine.2009.10.022.